PTEN loss is a likely marker of cancer initiation because biallelic deletion of Pten in transgenic mouse models is sufficient to induce HG-PIN in less oncogenic backgrounds such as C57BL/6 [55]. This evidence concerns the gene PTEN and prostate intraepithelial neoplasia.